BioTek Instruments is pleased to announce the expansion of their global operations with new offices in China and India. “These countries are devoting major resources toward the rapid growth of their respective pharmaceutical and biotechnology sectors,” stated Peter Weith, Vice President of Marketing & Sales at BioTek. “BioTek’s core microplate technologies will complement their associated investments in Life Science research, while allowing us to further build upon our global branding initiatives and service infrastructure.”

The company’s new office in China, BioTek Instruments Representative Office Beijing, has been opened in direct response to their expanding customer base and distribution partners throughout China. Chief Representative, Mr. Steven Fisher, and local staff will offer a high level of technical and sales support to China’s dramatically growing pharmaceutical market.

BioTek Instruments India (Pvt) Ltd., a joint venture with Medi-Spec Instruments India Pvt. Ltd., will be based in Mumbai under the leadership of Managing Director Vipul Chhatbar. Commenting on the new venture, Mr. Chhatbar noted, “Growth within the Indian sub-continent has been tremendous. The joint initiative between BioTek Instruments and Medispec India will allow us to remain a step ahead of our competition by leveraging our existing customer base with local currency and tax-free benefits.”

BioTek Instruments, Inc., headquartered in Winooski, VT, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. The BioTek Instruments, Inc. instrumentation is used to accelerate the drug discovery process, to advance discoveries in genomics and proteomics, and to aid in the advancement of life science research.


For further information, contact:

Chere Griffin
Shaw & Todd Advertising and Marketing Communications
908-668-1106 x15
cgriffin@shawtodd.com